Human Pro HGF Activator Antibody

Applications

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Preparation and Storage

Background: HGF Activator

Hepatocyte Growth Factor Activator (HGFA) is a serine endopeptidase that cleaves at the peptide bond between Arg494 and Val495 of single-chain human HGF precursor, generating the active heterodimer (1). HGFA is produced and secreted by the liver and normally circulates in the blood as an inactive zymogen (2, 3). The zymogen has a weak affinity for heparin but acquires a strong affinity for heparin upon activation that is linked to blood coagulation. This property may ensure the local action of this enzyme at the site of tissue injury (3). The 655 amino acid (aa) human HGFA precursor contains several predicted domains including a signal peptide (aa 1‑30), a propeptide (aa 31‑372), and a mature and active form (aa 373‑655) that is further processed into a short chain (aa 373‑407) and a long chain (aa 408‑655). The short chain and the long chain (catalytic domain) may form a disulfide-linked dimer. HGFA can be activated by thrombin or thermolysin (4). The active protease can be inhibited by HGFA inhibitors (HAIs). Two HAIs, HAI-1 and HAI-2, are known in mouse and human. HAI-1 is not only an inhibitor, but also a specific acceptor of active HGFA, acting as a reservoir of this enzyme on the cell surface (5).

Product Datasheets

Related Research Areas

• Alpha Granule Soluble Molecules
• Cytokines and Receptors in Angiogenesis
• Serine Proteases and Regulators